Enzyme research points to possible breast cancer target; Stem cell project could assist GI drug developers;

> Using X-ray crystallography, researchers determined the first crystal structures of an enzyme called DNA polymerase theta (POLQ), which may be a promising drug therapy target for inhibiting breast cancer. Release

> Scott Magness says he has figured out a way to isolate and grow thousands of elusive intestinal stem cells in the laboratory at time. The high-throughput process "promises to give scientists the ability to study stem cell biology and explore the origins of inflammatory bowel disease, intestinal cancers, and other gastrointestinal disorders." More

> Washington State University researchers say they discovered a mechanism by which omega-3 fatty acids can inhibit prostate cancer cells. The findings are at odds with a 2013 study asserting that omega-3s increase the risk of prostate cancer, possibly pointing the way to more effective anticancer drugs. Release

Sponsored By Paraza Pharma

Choosing the Right Pre-Clinical Collaborative Research Organization (CRO)

Learn about the key factors that are essential to creating a collaborative and productive working relationship to advance pre-clinical drug discovery programs.